» Authors » Toshikazu Hasuike

Toshikazu Hasuike

Explore the profile of Toshikazu Hasuike including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 15
Citations 57
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakamura K, Kim K, Yamamoto H, Sano M, Murai R, Hasuike T, et al.
JACC Case Rep . 2025 Jan; 30(1):102720. PMID: 39822804
A 51-year-old man with a history of antibiotic therapy for syphilis 1 month ago presented with syncope. Computed tomography revealed circumferential aortic wall thickening complicating severe stenosis of left main...
2.
Yamamoto H, Kuroda H, Hiroi T, Hasuike T, Doi A, Nishioka H
Intern Med . 2024 Nov; PMID: 39566983
Pott's puffy tumor is a rare complication of frontal sinusitis characterized by frontal bone osteomyelitis with a subperiosteal abscess typically presenting with forehead swelling. We herein report a 21-year-old man...
3.
Yamamoto H, Kuroda H, Hiramoto N, Hasuike T, Doi A, Nishioka H
J Infect Chemother . 2024 Apr; 30(12):1319-1323. PMID: 38670455
Nocardiosis in patients after allogeneic hematopoietic stem cell transplantation (HSCT) is rare, but is associated with a significant mortality risk. Although trimethoprim-sulfamethoxazole (TMP/SMX) remains the cornerstone of nocardiosis treatment, optimal...
4.
Izuta K, Matsuoka Y, Hasuike T, Hijikata Y, Kuwahara Y, Mizu D, et al.
Cureus . 2023 Oct; 15(9):e44650. PMID: 37799212
Aim: , a Gram-negative spiral bacterium, is a rare cause of bacteremia in humans. Unfortunately, little is known about infections in emergency departments (EDs). We aimed to describe the clinical...
5.
Doi A, Iwata K, Yamamoto T, Ogura A, Nasu S, Kuroda H, et al.
J Infect Chemother . 2023 Sep; 30(1):17-19. PMID: 37689135
Introduction: During the epidemic of the Omicron variant of SARS-CoV-2, nosocomial transmissions from healthcare workers (HCWs) to patients occur frequently. The influence of COVID-19 on hospitalized patients from nursing schools...
6.
Mitsuyuki S, Nishikubo M, Shimomura Y, Ohyama Y, Maruoka H, Nasu S, et al.
Eur J Haematol . 2023 Mar; 111(1):57-62. PMID: 36965014
Objectives: The higher risk of prolonged viral shedding in coronavirus disease (COVID-19) patients with hematological malignancies (HM) necessitates test-based de-isolation strategies. However, evidence to establish their appropriate isolation period is...
7.
Hasegawa K, Doi A, Kuroda H, Hasuike T, Ogura A, Nasu S, et al.
J Infect Prev . 2023 Feb; 24(2):83-88. PMID: 36811012
Background: We experienced a pseudo-outbreak of aspergillosis in a newly constructed COVID-19 ward. Within the first 3 months from the commencement of the ward, six intubated patients of COVID-19 developed...
8.
Doi A, Iwata K, Nakamura T, Oh K, Isome K, Hasegawa K, et al.
J Infect Chemother . 2022 Dec; 29(3):289-293. PMID: 36494058
Objectives: The emergence of the Alpha variant of novel coronavirus 2019 (SARS-CoV-2) is a concerning issue but their clinical implications have not been investigated fully. Methods: We conducted a nested...
9.
Imoto H, Yoshioka S, Nakagawa D, Hasegawa K, Kuroda H, Hasuike T, et al.
J Clin Lab Anal . 2022 Aug; 36(9):e24629. PMID: 35917437
Background: Cold agglutinin syndrome (CAS) is associated with various diseases. Several studies of CAS associated with coronavirus disease 2019 (COVID-19) reported hemolytic anemia and thrombosis; however, the clinical significance of...
10.
Doi A, Iwata K, Kuroda H, Hasuike T, Nasu S, Nishioka H, et al.
Medicine (Baltimore) . 2022 Jan; 100(48):e28066. PMID: 35049228
We conducted a study to estimate the seroprevalence of coronavirus disease 2019 (COVID-19) in Kobe, Japan with positive immunoglobulin G (IgG) rate of 3.3% (95% confidence interval [CI] 2.3%-4.6%) in...